首页|睾酮的临床用药研究进展与风险获益评估

睾酮的临床用药研究进展与风险获益评估

扫码查看
睾酮是人体重要的激素之一,男性缺乏睾酮激素会导致精神、生理等多方面功能障碍.睾酮补充治疗的临床有效性和安全性需通过临床试验、长期观察和药物相互作用评估确定,并密切监测患者的用药反应和相关不良事件发生情况.透皮贴剂等睾酮缓控释制剂可为治疗睾酮缺乏症(testosterone deficiency)提供较优选择.该文对国内外上市的睾酮剂型、给药途径、临床疗效以及其安全性作一综述,以期为临床相关用药提供参考.
Advances in the clinical use of testosterone and risk-benefit assessment
Testosterone is one of the most important hormones in the human body,and the lack of testosterone in men can lead to mental and physiological and other dysfunction.The clinical efficacy and safety of testosterone supplementation should be determined through clinical trials,long-term observation,and drug interaction evaluation,with close monitoring of patient responses and associated adverse events.Transdermal patch and other testosterone controlled release preparations provide a better choice for the treatment of testosterone deficiency.This article reviewed the testosterone dosage forms,administration routes,clinical efficacy and safety in domestic and foreign markets,in order to provide reference for the use of clinical related drugs.

testosteroneclinical medicationrisk-benefit assessment

陈凯栋、方泽卿、罗华菲

展开 >

华润紫竹药业有限公司,北京 100024

中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203

睾酮 临床用药 风险获益

2024

世界临床药物
上海医药工业研究院

世界临床药物

CSTPCD
影响因子:0.849
ISSN:1672-9188
年,卷(期):2024.45(12)